Associate Director, Nonclinical Development
Share
Job Location:
Las Vegas, NV - USA
Monthly Salary:
$ 205000 - 251000
Posted on:
10 hours ago
Vacancies:
1 Vacancy
Job Summary
Description
Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States IBSRELA (tenapanor) and XPHOZAH (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada.
Position Summary:
We are seeking an Associate Director of Nonclinical Development to join our experienced R&D team supporting drug development programs. The Associate Director will design and implement nonclinical strategies to evaluate and advance Ardelyxs drug candidates through different stages of development. This position involves designing and managing GLP safety studies at contract research organizations (CROs) for early and late-stage programs analyzing and interpreting safety data and collaborating with cross-functional teams.
Responsibilities:
- Oversee the conduct of nonclinical studies to support Ardelyx programs including non-GLP and GLP toxicology pharmacology and DMPK studies
- Identify/qualify new or existing CROs
- Serve as the Nonclinical representative during GLP audits
- Author and review SOPs and policies related to the Nonclinical function
- Oversee study logistics including managing contracts with vendors tracking invoices and payments and procuring/shipping study materials
- Conduct study monitoring visits
- Review and evaluate study protocols data and reports
- Author and review regulatory documents including IND NDA/BLA IB and DSUR
- Prepare and present study updates to internal project teams and senior management
Qualifications:
- PhD or advanced degree in toxicology pharmacology biology or related scientific discipline with 7 years of relevant work experience in the pharmaceutical industry or equivalent experience
- In-depth knowledge and technical oversight of nonclinical toxicology pharmacology and DMPK studies
- Experience conducting or overseeing nonclinical studies with small and large molecules is preferred
- Extensive knowledge of GLP principles and FDA/ICH guidelines
- Ability to analyze/interpret complex data and troubleshoot
- Highly organized with excellent written and oral communication skills
- Experience as a supervisor is a plus
- Ability to work effectively with cross-functional R&D colleagues
The anticipated annualized base pay range for this full-time position is $205000 - $251000. Ardelyx utilizes industry data to ensure that our compensation is competitive and aligned with our industry peers. Actual base pay will be determined based on a variety of factors including years of relevant experience training qualifications and internal equity. The compensation package may also include an annual bonus target and equity awards subject to eligibility and other requirements.
Ardelyx also offers a robust benefits package to employees including a 401(k) plan with generous employer match 12 weeks of paid parental leave up to 12 weeks of living organ and bone marrow leave equity incentive plans health plans (medical prescription drug dental and vision) life insurance and disability flexible time off annual Winter Holiday shut down and at least 11 paid holidays.
Ardelyx is an equal opportunity employer.
Required Experience:
Director
Key Skills
- Fundraising
- Management Experience
- Biotechnology
- Clinical Development
- Clinical Trials
- Research & Development
- Training & Development
- Grant Writing
- Economic Development
- Leadership Experience
- Public Speaking
- Product Development
About Company
From discovery through commercialisation, all of us at Ardelyx are driven to advance targeted therapies where significant medical needs persist.
